Geneva Biotech is a privately held biotechnology company, based in Geneva, Switzerland. Founded in 2012

Company

Intelligent DNA delivery systems

Welcome Guest \\ Login

Our Company

Geneva Biotech is a privately held biotechnology company, based in Geneva, Switzerland. Founded in 2012 as a spin-off of the European Molecular Biology Laboratory (EMBL), our vision is to develop a world class portfolio of viral and nonviral gene delivery systems and to market them across a broad spectrum of application fields.

Scientific Leadership

Photograph of Daniel Fitzgerald

Dr. Daniel Fitzgerald

CEO

Daniel received his PhD at Purdue University (USA), carried out his post graduate studies at ETH Zürich (Switzerland), and has a two decade long track record in publishing, patenting, and marketing novel biotechnologies. Daniel has been co-founder of two previous startups and has received several prestigious entrepreneurship prizes including the Venture prize from McKinsey & Company and the W.A. de Vigier Award.

Photograph of Imre Berger

Professor Imre Berger

Imre received his PhD at MIT (USA) and carried out his post graduate studies at ETH Zürich (Switzerland), and is Professor and Wellcome Trust Senior Investigator in Bristol, UK. Imre is a trained x-ray crystallographer, and is also interested in synthetic biology.

Business Development

Photograph of Imre Berger

Jackie Turnbull

Jackie is an experienced pharma/biotech industry professional with a long track record in deal making from both buy-side and sell-side.

Finances

Photograph of Sonia Timmerman

Sonya Timmerman

Sonya studied management and finance at Purdue University (USA), and is a CPA with nearly 20 years of industry finance experience. Sonya is heading our operations in USA as Managing Director.

Sales and Marketing

Photograph of Alicia Del Pierro

Alicia Del Pierro

Alicia studied molecular biology at the University of Southern California (USA), and leads our sales and marketing team.

Research Highlights

our r&d View all

Latest News

PRE-MRNA PROCESSING MACHINERY Published in Science using MultiBac: the structure of the human histone pre-mRNA 3′-end processing machinery ...

View all

Contact Us